Stock picks with research | support | resistance and technical analysis for trading | Day trading | stock investing in the market

• About US

Market Activity

Premium Plan

Trading Technologies

Day Trading

Stock Trading

Stock Trading Strategy

Technical Strategy

Breakout Stocks

Penny Stock investing

Stock Research for Breakout trading

LHC GROUP INC COM support | resistance | research

Stock : LHCG	\| Stock Recommendations : Buy
Sector : Healthcare	\| First resistance :
Stock Name : LHC GROUP INC COM	\| Second resistance :
Buy Near : 35.28	\| Third resistance :
StopLoss : 28.40	\| First Support : 30.27
Posted date : 11/2/2008 12:00:00 AM	\| Second Support : 28.40

LHC Group, Inc. com (LHCG) Stock given a breakout on 10/31/08 with good volume again many technical indicators also have given a buy signal, with rising moving average. Stockhastic and ADX also given a buy signal.

LHC Group, Inc. com (LHCG) announced on 10/29/08 that its net revenue for third quarter increased 26.7 % and for nine months revenue increased 25.4 % and also increase revenue guidance. LHC Group, Inc. com (LHCG) is one of the largest providers of home nursing services. As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. LHC Group, Inc. com (LHCG) Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to Stock market and economic condition keep tight stop loss on all position. You can buy this Stock near $22.00

Stock research

Recent News Head Lines

LHC Group (LHCG) Q4 Earnings Beat Estimates, Revenues Miss
(Fri, 26 Feb 2021 14:22:02 +0000)
LHC Group's (LHCG) fourth-quarter results benefit from organic growth in home health and hospice admissions.

LHC Group, Inc. to Host Earnings Call
(Fri, 26 Feb 2021 11:45:00 +0000)
NEW YORK, NY / ACCESSWIRE / February 26, 2021 / LHC Group, Inc. (NASDAQ:LHCG) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 26, 2021 at 9:00 AM Eastern Time.

LHC Group Slips 5.9% After-Hours On Tepid 1Q Outlook
(Fri, 26 Feb 2021 08:55:49 +0000)
LHC Group reported mixed 4Q results. Shares of the health care provider fell 5.9% in Thursday’s extended trading after issuing a 1Q outlook that came in below the Street's estimates. LHC Group (LHCG) posted adjusted earnings of $1.40 per share in 4Q, which grew 21.7% year-over-year and beat analysts’ expectations of $1.39 per share. The company’s net service revenues increased marginally to $532.3 million. However, analysts were expecting revenues of $534.9 million. Adjusted EBITDA rose 28.3% year-over-year to $68.4 million. The company’s CEO Keith G. Myers said, “The swift, comprehensive approach we took to the public health emergency caused by COVID-19 had a positive impact on the evolution of healthcare delivery models, helped to protect our employees and patients, boosted our organic growth trajectory and strengthened our value proposition to patients, partners and payors.” Looking ahead, the company projects 1Q net service revenues in the range of $515-$530 million, lower than analysts’ expectations of about $542 million. 1Q earnings are forecast to be between $1.20 and $1.30 per share, also lower than the consensus estimates of $1.37 per share. (See LHC Group stock analysis on TipRanks) As for 2021, the company expects to generate net service revenue in the range of $2.2-$2.26 billion and adjusted earnings of between $5.65 and $5.90 per share. Analysts were expecting 2021 revenues of $2.26 billion and earnings of $5.90 per share. Following the results, Oppenheimer analyst Michael Wiederhorn maintained a price target of $250 (33% upside potential) and a Buy rating on the stock. In a note to investors, Wiederhorn said, “We favor home health due to its promising growth, led by a shift from the institutional setting into the home. Furthermore, we believe the larger providers will lead a consolidation of this fragmented industry, especially as reimbursement rates become tighter and reimbursement systems become more complex.” Overall, consensus among analysts is a Strong Buy based on 6 unanimous Buy recommendations. The average analyst price target of $254.67 implies upside potential of about 35% to current levels. Shares have gained by around 25% over the past year. Related News:Clear Channel Posts Better-Than-Expected Sales; Shares SurgePapa John’s Misses Earnings Estimates; Shares SlipSage Posts Surprise Quarterly Profit As Sales Surge; Shares Pop 6% More recent articles from Smarter Analyst: Arcosa’s 2021 Revenue Outlook Disappoints After 4Q Miss; Stock Plunges 16% Terminix’s 4Q Profit Spikes 163%; Shares Gain Werner Bumps Up Quarterly Dividend By 11%; Street Sees 8% Upside Nektar Posts Better-Than-Feared Quarterly Loss, Misses On Revenues

LHC Group's (NASDAQ:LHCG) Wonderful 410% Share Price Increase Shows How Capitalism Can Build Wealth
(Fri, 26 Feb 2021 07:05:54 +0000)
LHC Group, Inc. ( NASDAQ:LHCG ) shareholders might be concerned after seeing the share price drop 13% in the last...

LHC Group (LHCG) Tops Q4 Earnings Estimates
(Fri, 26 Feb 2021 00:20:12 +0000)
LHC (LHCG) delivered earnings and revenue surprises of 2.19% and -0.25%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Never go against major trend for day trading | breakout stock trading Before to invest learn day trading strategies online stock trading system stock investing tips stock research .

Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research

All Rights Reserved © 2000-2006 Flyingstock.com
Chart courtesy of StockCharts.com
Breakout Stock trading - LHC GROUP INC COM research | day trading | stock investing

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.